Institutions / Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB
CIK 1599882 · Institution · as of Dec 31, 2025
Portfolio value
$1.07B
Positions
94
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 94 →
| Company | Value | % of portfolio |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $47.39M | 4.4% |
| ELI LILLY & Co | $45.37M | 4.2% |
| Boston Scientific Corp | $41.12M | 3.8% |
| Medtronic plc | $28.43M | 2.7% |
| Intuitive Surgical Inc | $27.19M | 2.5% |
| Cooper Companies, Inc. | $26.84M | 2.5% |
| CVS HEALTH Corp | $26.63M | 2.5% |
| AbbVie Inc. | $25.27M | 2.4% |
| Glaukos Corp | $23.71M | 2.2% |
| Danaher Corp /De | $22.67M | 2.1% |
| Cencora Inc | $21.40M | 2.0% |
| Vera Therapeutics, Inc. | $21.27M | 2.0% |
| McKesson Corp | $21.00M | 2.0% |
| Axsome Therapeutics, Inc. | $20.97M | 2.0% |
| Alignment Healthcare, Inc. | $19.94M | 1.9% |
| Insmed Inc | $19.77M | 1.8% |
| Thermo Fisher Scientific Inc. | $19.49M | 1.8% |
| PROCEPT BioRobotics Corp | $19.22M | 1.8% |
| Alnylam Pharmaceuticals Inc | $18.16M | 1.7% |
| Unitedhealth Group Inc | $18.12M | 1.7% |
| Neurocrine Biosciences Inc | $17.80M | 1.7% |
| Insulet Corp | $17.34M | 1.6% |
| Doximity, Inc. | $16.51M | 1.5% |
| Edwards Lifesciences Corp | $16.50M | 1.5% |
| Nuvalent, Inc. | $16.43M | 1.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.